Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1499 Records) |
| Query Trace: Ovarian Neoplasms and BRCA1[original query] |
|---|
| Ovarian Cancer Patient-Derived Organoids Used as a Model for Replicating Genetic Characteristics and Testing Drug Responsiveness: A Preliminary Study. Cell transplantation 2024 9 33 9636897241281869. Yu-Hsun Chang, Kun-Chi Wu, Kai-Hung Wang, Dah-Ching Di |
| Screening Familial Risk for Hereditary Breast and Ovarian Cancer. JAMA network open 2024 9 7 (9): e2435901. Daniel Kiser, Gai Elhanan, Alexandre Bolze, Iva Neveux, Karen A Schlauch, William J Metcalf, Elizabeth T Cirulli, Catherine McCarthy, Leslie A Greenberg, Savanna Grime, Jamie M Schnell Blitstein, William Plauth, Joseph J Grzyms |
| Identification of ubiquitin markers for survival and prognosis of ovarian cancer. Heliyon 2024 9 10 (18): e37288. Yiwen Feng, Liyun Shan, Yanping Gong, Wenzhao Hang, Zhenyu Sang, Yunyan Sun, Kefu Tang, Yulan Wang, Binjie Hu, Xiaowei |
| Evaluation of the Oncomine Comprehensive Assay Plus NGS Panel and the OncoScan CNV Assay for Homologous Recombination Deficiency Detection. Molecular diagnosis & therapy 2024 9 . Lone Schejbel, Tim Svenstrup Poulsen, Lau Kræsing Vestergaard, Ib Jarle Christensen, Estrid Høgda |
| Blood molybdenum level as a marker of cancer risk on BRCA1 carriers. Hereditary cancer in clinical practice 2024 9 22 (1): 19. Milena Matuszczak, Adam Kilja?czyk, Wojciech Marciniak, Ró?a Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bry?kiewicz, Cezary Cybulski, Tadeusz D?bniak, Gronwald Jacek, Tomasz Huzarski, Marcin Lener, Anna Jakubowska, Sandra Pietrzak, Marek Szwiec, Ma?gorzata Stawicka-Nie?acna, Dariusz Godlewski, Artur Prusaczyk, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Ewa Kilar-Kobierzycka, Monika Sio?ek, Renata Posmyk, Joanna Jarkiewicz-Tretyn, Rodney Scott, Steven Narod, Jan Lubi?s |
| Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort. Cancers 2024 9 16 (17): . Ava Kwong, Cecilia Y S Ho, Henry C M Leung, Amy W S Leung, Chun-Hang Au, Edmond S K |
| Predicting BRCA mutation and stratifying targeted therapy response using multimodal learning: a multicenter study. Annals of medicine 2024 9 56 (1): 2399759. Yi Li, Xiaomin Xiong, Xiaohua Liu, Mengke Xu, Boping Yang, Xiaoju Li, Yu Li, Bo Lin, Bo |
| Mayo Clinic Tapestry Study: A Large-Scale Decentralized Whole Exome Sequencing Study for Clinical Practice, Research Discovery, and Genomic Education. Mayo Clinic proceedings 2024 12 . Lorelei A Bandel, Robert A Vierkant, Teresa M Kruisselbrink, Michelle L Bublitz, Tammy A Wilson, Sebastian M Armasu, Jan B Egan, Richard J Presutti, Niloy Jewel J Samadder, Aleksandar Sekulic, Rory J Olson, Jennifer Tan-Arroyo, Joel A Morales-Rosado, Eric W Klee, Matthew J Ferber, Jennifer L Kemppainen, Jennifer L Anderson, Jessa S Bidwell, Joseph J Wick, Victor E Ortega, William V Bobo, Pavel N Pichurin, Jessica M Mcmillan, DeAnna M Weaver, Douglas L Riegert-Johnson, Alanna M Cera, Lauren M Boucher, Iftikhar J Kullo, Sarah K Mantia, Matthew T Jones, Nicholas B Larson, Tony C Luehrs, Jon W Leitzke, Hugues Sicotte, Shulan Tian, Jennifer R Stavlund, Joel E Pacyna, Richard R Sharp, Akwasi A Asabere, James Lu, Tammy M McAllister, T'Nita S Walker, A Keith Stewart, Gianrico Farrugia, Konstantinos N Lazarid |
| Mutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population. Asian Pacific journal of cancer prevention : APJCP 2024 12 25 (12): 4145-4151. Kunjal Lila, Harshita Bhanushali, MIlind Chanekar, Raj Jatale, Monisha Banerjee, Rakhi Bajpai Dixit, Aparna Rajadhyaksha, Kirti Chad |
| Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024 12 51 (3): 109380. Quratul Ain, Rachel L O'Connell, Parinita Swarnkar, Terri McVeigh, Angela George, Marios K Tasoulis, Gerald Ph Gui, Jennifer Wiggins, Aadil A Khan, Katherine Dc Krupa, Peter A Barry, Susana Banerjee, Jennifer E Rus |
| Contribution of large genomic rearrangements in BRCA1/2 genes and CHEK2 1100delC allele variant to the development of breast/ovarian cancer in Argentinian population. Breast cancer research and treatment 2024 12 . Luciana Berlanga, Vanesa Lotersztein, Eliseo I Aranda, Roxana Cerreti |
| Patterns of genomic instability in?>?2000 patients with ovarian cancer across six clinical trials evaluating olaparib. Genome medicine 2024 12 16 (1): 145. Alan Barnicle, Isabelle Ray-Coquard, Etienne Rouleau, Karen Cadoo, Fiona Simpkins, Carol Aghajanian, Alexandra Leary, Andrés Poveda, Stephanie Lheureux, Eric Pujade-Lauraine, Benoit You, Jonathan Ledermann, Ursula Matulonis, Charlie Gourley, Kirsten M Timms, Zhongwu Lai, Darren R Hodgson, Cathy E Elks, Simon Dearden, Coumaran Egile, Pierre Lao-Sirieix, Elizabeth A Harrington, Jessica S Bro |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International journal of molecular sciences 2024 12 25 (23): . Petra Nagy, János Papp, Vince Kornél Grolmusz, Anikó Bozsik, Tímea Pócza, Edit Oláh, Attila Patócs, Henriett Bu |
| BRCA1 Protein Expression in Epithelial Ovarian Cancer and Associated Clinicopathological Factors in Uganda. Obstetrics and gynecology international 2024 11 2024 9527113. Tonny Okecha, Derrick B Abila, Dorothy L Nabbale, Fauz Katongole, James J Yahaya, Robert Lukande, Sam Kalungi, Hawa Nalwo |
| Correction to "Mutation spectra of the BRCA1/2 genes in human breast and ovarian cancer and germline". Environmental and molecular mutagenesis 2024 11 65 (6-7): 230. Authors are not available |
| Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age-a systematic review. Frontiers in global women's health 2024 11 5 1487820. Shayesteh Jahanfar, Julie Mortazavi, Amy Lapidow, Cassandra Cu, Jude Al Abosy, Kathyrn Morris, Juan Camilo Becerra-Mateus, Meredith Steinfeldt, Olivia Maurer, Jiang Bohang, Paola Andrenacci, Marwa Badawy, Moazzam A |
| BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer. Clinical epigenetics 2024 11 16 (1): 171. Heidelinde Fiegl, Simon Schnaiter, Daniel U Reimer, Katharina Leitner, Petra Nardelli, Irina Tsibulak, Verena Wieser, Katharina Wimmer, Esther Schamschula, Christian Marth, Alain G Zeim |
| Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging in Magnetic Resonance in the Assessment of Peritoneal Recurrence of Ovarian Cancer in Patients with or Without BRCA Mutation. Cancers 2024 11 16 (22): . Melania Jankowska-Lombarska, Laretta Grabowska-Derlatka, Leszek Kraj, Pawel Derlat |
| Pattern Anlysis of Risk-Reducing Strategies in Unaffected Korean BRCA1/2 Mutation Carriers. Current oncology (Toronto, Ont.) 2024 11 31 (11): 6767-6777. Dabin Kim, Jai Min Ryu, Sang-Ah Han, Zisun Kim, Sung-Won K |
| Clinical Outcomes of Poly(ADP-Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea. Current oncology (Toronto, Ont.) 2024 11 31 (11): 6711-6722. Hyeong In Ha, Hyung Joon Yoon, Changho Song, Eun Taeg Kim, Dong-Soo Suh, Ki Hyung Kim, Yong Jin Na, Yong Jung So |
| The impact of pathogenic BRCA1/2 tumor mutation status on high grade serous epithelial ovarian cancer survival outcome: A multicenter study from Indonesia. SAGE open medicine 2024 11 12 20503121241299849. Sutrisno Sutrisno, Dina Marlina, Kevin Dominique Tjandraprawira, Putri Nadhira Adinda Adriansy |
| Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer. British journal of cancer 2024 11 . Robert D Morgan, Xin Wang, Bethany M Barnes, Laura Spurgeon, Aurore Carrot, Daniel Netto, Jurjees Hasan, Claire Mitchell, Zena Salih, Sudha Desai, Joseph Shaw, Brett Winter-Roach, Helene Schlecht, George J Burghel, Andrew R Clamp, Richard J Edmondson, Benoit You, D Gareth R Evans, Gordon C Jayson, Stephen S Tayl |
| Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. JCO global oncology 2024 11 10 e2400352. Rifaat R Rawashdeh, Holly Pederson, Rafal Iskanderian, Fawad Khan, Basel Altrabulsi, Stephanie Ricci, Charis Eng, Bassel Jallad, Asma Ibrahim Al Mannaei, Mohamed Salem Alameri, Azza Attia, Stephen R Grobmy |
| The discrepancy of somatic BRCA1/2 pathogenic variants from two different platforms in epithelial ovarian, fallopian tube, and peritoneal cancer. Scientific reports 2024 10 14 (1): 25879. Ji Hyun Kim, Jun-Young Shin, Seog-Yun Park, Sang-Soo Seo, Sokbom Kang, Chong Woo Yoo, Sang-Yoon Park, Myong Cheol L |
| PALB2 analysis in the diagnostic process of breast cancer: An Italian monocentric experience. Tumori 2024 10 3008916241290738. Maria Grazia Tibiletti, Ileana Carnevali, Sofia Facchi, Laura Libera, Corrado Chiappa, Fausto Sessa, Stefano La Rosa, Francesca Rove |
| Two founder variants account for over 90% of pathogenic BRCA alleles in the Orkney and Shetland Isles in Scotland. European journal of human genetics : EJHG 2024 10 . Shona M Kerr, Lucija Klaric, Marisa D Muckian, Emma Cowan, Lesley Snadden, Gannie Tzoneva, Alan R Shuldiner, Zosia Miedzybrodzka, James F Wils |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. Revista da Associacao Medica Brasileira (1992) 2024 10 70 (10): e20240534. Ferah Kazanci, Zerrin Y?lmaz Çelik, Mert Polat, Ferhat Karademir, Ozlem Erdem, Feride ?ffet ?ahin, Mehmet Anil On |
| Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data. Breast cancer research and treatment 2024 10 . Nana Komatsu, Takashi Chishima, Chie Watanabe, Kanae Taruno, Mayuko Inuzuka, Masanori Oshi, Masami Arai, Seigo Nakamu |
| Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer. Cancer science 2024 10 . Maiko Miwa, Masakazu Kitagawa, Yuka Asami, Mayumi Kobayashi-Kato, Takafumi Watanabe, Aiko Ogasawara, Kengo Hiranuma, Hisamori Kato, Motonobu Saito, Yohei Miyagi, Tomoyasu Kato, Hiroshi Yoshida, Yukihide Momozawa, Takashi Kohno, Kouya Shiraishi, Kosei Hasega |
| Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population. Breast cancer research : BCR 2025 1 27 (1): 7. Dione Aguilar, María Lourdes Garza-Rodríguez, Carolina Elizabeth Muñiz-Garza, Fernando Alcorta Nuñez, Cynthia Mayte Villarreal-Garza, Oscar Vidal-Gutiérrez, Diana Cristina Pérez-Ibave, Carlos Horacio Burciaga-Flor |
- Page last reviewed:Feb 1, 2024
- Content source: